BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image
Active

Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Ltd IPO Details

IPO Date

20 Dec 2024 - 24 Dec 2024

Listing Date

30 Dec 2024

Face Value

10

Price

₹372 - ₹391 per share

Lot Size

1 Lot (38 Shares)

Listing At

BSE, NSE

Employee Discount

₹0 per share

Issue Type

Book Building

Minimum Investment

₹14,858 / 1 Lot

Maximum Investment

₹1,93,154 / 13 Lot

Total Issue Size

₹582.11 Crores

Fresh Issue

₹500 Crores

Offer For Sale

NA

Retail Discount

₹0

Shareholding Pre Issue

3,32,65,865 Shares

Shareholding Post Issue

4,60,53,589 Shares

info

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Bidding starts

20th Dec

tick

Bidding ends

24th Dec

tick

Allotment of shares

26th Dec

tick

Initiation of refund

26th Dec

tick

Credit of shares to Demat account

27th Dec

tick

Listing date

30th Dec

About Senores Pharmaceuticals Ltd IPO

Founding Year: 2017

Managing Director: Swapnil Jatinbhai Shah

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 66.66% 45.76%
Public Group 33.34% 54.24%

Senores Pharmaceuticals Ltd IPO Reservation

QIB Shares Offered 44,43,817 (29.85%)
NII (HNI) Shares Offered 22,21,909 (14.92%)
Retail Shares Offered 14,81,272 (9.95%)
Anchor Investor Shares Offered 66,65,726 (44.77%)
Total Shares Offered 1,48,87,724
Total Shares With Anchor Investor 1,48,87,724

Senores Pharmaceuticals Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 38 ₹14,858
Retail (Max) 13 494 ₹1,93,154
S HNI (Min) 14 532 ₹2,08,012
S HNI (Max) 67 2,546 ₹9,95,486
B HNI (MIN) 68 2,584 ₹10,10,344

Senores Pharmaceuticals Ltd IPO Anchor Investor Details

Bid Date December 19, 2024
Shares Offered 0
Anchor Investment Details 0

Senores Pharmaceuticals Ltd IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 8108114949
Email Id senorespharma.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Senores Pharmaceuticals Ltd IPO Lead Manager

1. Equirus Capital Pvt Ltd

2. Ambit Pvt Ltd

3. Nuvama Wealth Management Ltd

Senores Pharmaceuticals Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹707.97 ₹168.12 ₹38.92
Reserves and Surplus ₹661.92 ₹137.61 ₹29.11
Total Borrowing ₹93.97 ₹92.76 ₹60.41

Senores Pharmaceuticals Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 45,93,216 43,47,78,102 94.66
Non Institutional Investors (NIIs) 23,19,879 22,29,63,632 96.11
NII(Bid amount of more than Ten Lakh Rupees) 15,46,586 14,46,53,764 93.53
NII(Bid amount of more than 2 Lakh < 10 Rupees) 7,73,293 7,83,09,868 101.27
Retail Individual Investors (RIIs) 15,46,586 13,79,96,278 89.23
Total 85,34,681 79,72,32,134 93.41

Strength of Senores Pharmaceuticals Ltd

  • Ability to cater to the Regulated Markets of US, Canada and the United Kingdom through our US FDA approved formulation manufacturing facility in the US.
  • Distinct niche product portfolio built in a short span for Regulated Markets of US, Canada and the United Kingdom.
  • Long-term marketing arrangements with pharmaceutical companies in the Regulated Markets, US, Canada and the United Kingdom.
  • Presence in the Emerging Markets with a product portfolio, including specialty or complex products.
  • R&D capabilities driving our differentiated portfolio of products.
  • Professional management teams for our diverse business verticals.

Risks Involved

  • The company business is dependent on the sale of its products through third party marketing partners and distributors. The loss of one or more marketing partners or distributors, the deterioration of their financial condition or prospects, or a reduction in their demand for its products or the company inability to maintain and increase the number of its arrangements for the marketing and distribution of the company products could adversely affect its business, results of operations, financial conditions and cash flows.
  • The company business is dependent on the sale of its products and continued growth of the Regulated Markets. Decrease in market growth for its product or failures to respond to change in market conditions could adversely affect its business, results of operations, financial conditions and cash flows.
  • Failures to comply with the quality standards and technical specifications prescribed by its customers may lead to loss of business from such customers and could negatively impact its business, results of operations and financial condition, including cancellation of existing and future orders which may expose it to warranty claims.
  • The company derives a part of its revenue from few customers. If one or more of such customers choose not to source their requirements from it or to terminate the company contracts or purchase orders, its business, cash flows, financial condition and results of operations may be adversely affected.
  • The company has had negative cash flows from operating activities in the last three Fiscal years and may continue to have negative cash flows in the future which could have an impact on its business and operations.
  • The pharmaceutical market is subject to regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose it to litigation or other liabilities, which could adversely affect its reputation, business, financial condition and results of operations. There have been instances in the past where the company drugs failed to meet standards prescribed under applicable law and action was taken against it by regulatory authorities.
  • The company derives a major portion of its revenue from its operations in the United States. A reduction in demand for the company products in these regions could adversely affect its business, results of operations, financial conditions and cash flows.
  • Any manufacturing or quality control problems may damage its reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, results of operations and financial condition.
  • Some of its Directors and Promoters may have interest in entities, which are in businesses similar to its and this may result in conflict of interest with it. Further, certain of its Promoter Group, Subsidiaries and Group Companies are in the same line of business as it, which may result in a conflict of interest.
  • The erstwhile statutory auditors of the Company have issued a qualified opinion in connection with their audit report for Fiscal 2022.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Curis Lifesciences Limited IPO
Bidding Period
7th Nov 2025 - 11th Nov 2025
Price Range
₹120.0 - 128.0
IPO Size
₹0
Mahamaya Lifesciences Limited IPO
Bidding Period
11th Nov 2025 - 11th Nov 2025
Price Range
₹108.0 - 114.0
IPO Size
₹0
Pine Labs Limited IPO
Bidding Period
7th Nov 2025 - 11th Nov 2025
Price Range
₹210.0 - 221.0
IPO Size
₹0
Shining Tools Limited IPO
Bidding Period
7th Nov 2025 - 11th Nov 2025
Price Range
₹114.0 - 114.0
IPO Size
₹0
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aequs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amagi Media Labs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
STUDDS ACCESSORIES LIMITED IPO
Bidding Period
30th Oct 2025 - 11th Nov 2025
Price Range
₹557.0 - 585.0
IPO Size
₹4,55,49,00,000
ORKLA INDIA LIMITED IPO
Bidding Period
29th Oct 2025 - 10th Oct 2025
Price Range
₹695.0 - 730.0
IPO Size
₹16,67,54,00,000
SAFECURE SERVICES LIMITED IPO
Bidding Period
29th Oct 2025 - 10th Oct 2025
Price Range
₹102.0 - 102.0
IPO Size
₹30,60,00,000
GAME CHANGERS TEXFAB LIMITED IPO
Bidding Period
28th Oct 2025 - 10th Oct 2025
Price Range
₹96.0 - 102.0
IPO Size
₹54,84,00,000
JAYESH LOGISTICS LIMITED IPO
Bidding Period
27th Oct 2025 - 10th Oct 2025
Price Range
₹116.0 - 122.0
IPO Size
₹28,64,00,000
MIDWEST LIMITED IPO
Bidding Period
15th Oct 2025 - 10th Oct 2025
Price Range
₹1014.0 - 1065.0
IPO Size
₹4,51,00,00,000
CANARA HSBC LIFE INSURANCE COMPANY LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹100.0 - 106.0
IPO Size
₹25,17,50,00,000
SK MINERALS AND ADDITIVES LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹120.0 - 127.0
IPO Size
₹41,15,00,000
SHLOKKA DYES LIMITED IPO
Bidding Period
30th Sep 2025 - 10th Oct 2025
Price Range
₹88.0 - 91.0
IPO Size
₹60,33,00,000
SIHORA INDUSTRIES LIMITED IPO
Bidding Period
10th Oct 2025 - 10th Oct 2025
Price Range
₹66.0 - 66.0
IPO Size
₹10,56,00,000
CANARA ROBECO ASSET MANAGEMENT COMPANY LIMITED IPO
Bidding Period
9th Oct 2025 - 10th Oct 2025
Price Range
₹253.0 - 266.0
IPO Size
₹13,26,13,00,000
RUBICON RESEARCH LIMITED IPO
Bidding Period
9th Oct 2025 - 10th Oct 2025
Price Range
₹461.0 - 485.0
IPO Size
₹13,77,50,00,000
MITTAL SECTIONS LIMITED IPO
Bidding Period
7th Oct 2025 - 10th Oct 2025
Price Range
₹136.0 - 143.0
IPO Size
₹52,91,00,000
LG ELECTRONICS INDIA LIMITED IPO
Bidding Period
7th Oct 2025 - 10th Oct 2025
Price Range
₹1080.0 - 1140.0
IPO Size
₹1,16,07,01,00,000
TATA CAPITAL LIMITED IPO
Bidding Period
6th Oct 2025 - 10th Oct 2025
Price Range
₹310.0 - 326.0
IPO Size
₹1,55,11,87,00,000
WEWORK INDIA MANAGEMENT LIMITED IPO
Bidding Period
3rd Oct 2025 - 10th Oct 2025
Price Range
₹615.0 - 648.0
IPO Size
₹30,00,00,00,000
NSB BPO SOLUTIONS LIMITED IPO
Bidding Period
23rd Sep 2025 - 10th Oct 2025
Price Range
₹121.0 - 140.0
IPO Size
₹74,20,00,000
GREENLEAF ENVIROTECH LIMITED IPO
Bidding Period
30th Sep 2025 - 10th Oct 2025
Price Range
₹136.0 - 136.0
IPO Size
₹21,90,00,000
SHIPWAVES ONLINE LIMITED IPO
Bidding Period
30th Sep 2025 - 10th Oct 2025
Price Range
₹12.0 - 12.0
IPO Size
₹56,35,00,000
SHEEL BIOTECH LIMITED IPO
Bidding Period
30th Sep 2025 - 10th Oct 2025
Price Range
₹59.0 - 63.0
IPO Size
₹34,02,00,000
  • All
  • MainBoard
  • SME
JAYESH LOGISTICS LIMITED IPO
Issue Prize
122.00
Listing Day Close
117.80(-3.28%)
MIDWEST LIMITED IPO
Issue Prize
1065.00
Listing Day Close
1141.10(7.14%)
CANARA HSBC LIFE INSURANCE COMPANY LIMITED IPO
Issue Prize
106.00
Listing Day Close
111.50(5.66%)
SK MINERALS AND ADDITIVES LIMITED IPO
Issue Prize
127.00
Listing Day Close
152.25(19.69%)
SHLOKKA DYES LIMITED IPO
Issue Prize
91.00
Listing Day Close
85.50(-5.49%)
SIHORA INDUSTRIES LIMITED IPO
Issue Prize
66.00
Listing Day Close
66.50(1.52%)
CANARA ROBECO ASSET MANAGEMENT COMPANY LIMITED IPO
Issue Prize
266.00
Listing Day Close
300.25(12.78%)
RUBICON RESEARCH LIMITED IPO
Issue Prize
485.00
Listing Day Close
627.45(29.28%)
MITTAL SECTIONS LIMITED IPO
Issue Prize
143.00
Listing Day Close
108.70(-23.78%)
LG ELECTRONICS INDIA LIMITED IPO
Issue Prize
1140.00
Listing Day Close
1689.40(48.16%)
TATA CAPITAL LIMITED IPO
Issue Prize
326.00
Listing Day Close
330.40(1.23%)
WEWORK INDIA MANAGEMENT LIMITED IPO
Issue Prize
648.00
Listing Day Close
624.75(-3.55%)
NSB BPO SOLUTIONS LIMITED IPO
Issue Prize
140.00
Listing Day Close
121.30(-13.57%)
GREENLEAF ENVIROTECH LIMITED IPO
Issue Prize
136.00
Listing Day Close
132.90(-2.21%)
DSM FRESH FOODS LIMITED IPO
Issue Prize
100.00
Listing Day Close
126.00(26.00%)
SHEEL BIOTECH LIMITED IPO
Issue Prize
63.00
Listing Day Close
95.55(52.38%)
SUNSKY LOGISTICS LIMITED IPO
Issue Prize
46.00
Listing Day Close
53.55(17.39%)
VALPLAST TECHNOLOGIES LIMITED IPO
Issue Prize
54.00
Listing Day Close
58.63(9.26%)
CHIRAHARIT LIMITED IPO
Issue Prize
21.00
Listing Day Close
15.96(-23.81%)
BAG CONVERGENCE LIMITED IPO
Issue Prize
87.00
Listing Day Close
106.05(21.84%)

Frequently Asked Questions

What is Senores Pharmaceuticals Ltd IPO?

Answer Field

Senores Pharmaceuticals Ltd IPO is a Mainboard IPO of 1,48,87,724 equity shares of a face value of ₹10 aggregating up to ₹582.11 Crores. The issue is priced at ₹372 to ₹391 per share. The minimum order quantity is 38 Shares. The IPO opens on December 20, 2024, and closes on December 24, 2024. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Senores Pharmaceuticals Ltd IPO will open?

Answer Field

The Senores Pharmaceuticals Ltd IPO opens on December 20, 2024 and closes on December 24, 2024.

What is the lot size of Senores Pharmaceuticals Ltd?

Answer Field

Senores Pharmaceuticals Ltd lot size is 38 shares, and the minimum amount required is ₹14,858.

How to apply for Senores Pharmaceuticals Ltd IPO?

Answer Field

You can apply in Senores Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Senores Pharmaceuticals Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Senores Pharmaceuticals Ltd IPO will be done on December 26, 2024, and the allotted shares will be credited to your demat account by December 27, 2024.

When is Senores Pharmaceuticals Ltd IPO listing date?

Answer Field

The Senores Pharmaceuticals Ltd listing date is December 30, 2024.

Who is the registrar of Senores Pharmaceuticals Ltd IPO?

Answer Field

The registrar of Senores Pharmaceuticals Ltd IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Equirus Capital Pvt Ltd,Ambit Pvt Ltd,Nuvama Wealth Management Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Senores Pharmaceuticals Ltd IPO?

Answer Field

The fresh issue size is ₹500 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Senores Pharmaceuticals Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 38 shares and ₹14,858 amount.

How can I approve the UPI mandate request for Senores Pharmaceuticals Ltd IPO?

Answer Field

To apply for Senores Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Senores Pharmaceuticals Ltd?

Answer Field

The price of each Senores Pharmaceuticals Ltd share will be ranging in between ₹372 to ₹391 per share.

What is the cut-off time for the UPI mandate for Senores Pharmaceuticals Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 24, 2024.

No results found

banner-icon

Open Your Free Demat Account

Enjoy zero brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy zero brokerage on delivery trades

+91

|